Future of PARP inhibitors in cancer treatment: overcoming resistance and enhancing efficacy with combination therapies. [PDF]
Shoaib M +6 more
europepmc +1 more source
[Epithelial-mesenchymal Transition: Biological Basis and Clinical Prospects of Lung Cancer Invasion, Metastasis, and Drug Resistance]. [PDF]
Sun H, Xiong M, Xie S, Wen J.
europepmc +1 more source
[Etiological characteristics and drug resistance in patients with hepatitis B virus-associated acute-on-chronic liver failure combined with intra-abdominal infection]. [PDF]
Yu XL, Xie HB, Luo YQ, Zeng YY.
europepmc +1 more source
[Refractory or resistant cytomegalovirus infections after hematopoietic stem cell transplantation: diagnosis and management]. [PDF]
Zhang XY, Jiang EL.
europepmc +1 more source
[A cross-sectional study on the pathogen composition and antimicrobial resistance in neonates with sepsis in Hebei Province, China]. [PDF]
Hebei Neonatal Sepsis Research Group.
europepmc +1 more source
[Changes and Trends of Drug Resistance of Pathogenic Bacteria in Blood Samples of a Tertiary-Level Teaching Hospital from 2016 to 2020]. [PDF]
Deng J, Kang M, Xie Y, Ma Y.
europepmc +1 more source
[Distribution and Antibiotic Resistance Analysis of Ocular Bacterial Pathogens at a Tertiary Hospital From 2012 to 2021]. [PDF]
Zhou D, Wang Y, Deng J, Xiao Y, Xie Y.
europepmc +1 more source
[Impact of primary duodenogastric reflux and Helicobacter pylori infection on gastritis and antibiotic resistance in children]. [PDF]
Wang XY, Lin Q.
europepmc +1 more source
Surveillance of antimicrobial resistance by a global network of WHO collaborating centres. [PDF]
Harant A +20 more
europepmc +1 more source

